As a sodium-glucose cotransporter 2 (SGLT2) inhibitor, Empagliflozin has shown good efficacy in the treatment of type 2 diabetes mellitus, heart failure, and chronic kidney disease. With its increasingly widespread clinical application, issues such as how to obtain the medication through formal channels, avoid purchasing risks, and identify the authenticity of products have become major concerns for patients.

How to Purchase Empagliflozin

Overseas Purchase

Patients may choose to consult and purchase Empagliflozin at hospital pharmacies or legitimate drugstores in countries or regions where the medication has been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase through Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and can offer professional consultation and guidance.

Precautions for Purchasing Empagliflozin

Strictly Follow Doctor's Instructions for Medication Use

The recommended dosage is 10 mg orally once daily in the morning, which can be taken with food or on an empty stomach.

For additional blood glucose control, the dosage may be increased to 25 mg orally once daily in patients who tolerate Jardiance well.

Precautions for Contraindicated Populations

It is not recommended for improving blood glucose control in patients with type 1 diabetes mellitus.

It is not recommended for blood glucose control in patients with type 2 diabetes mellitus who have an estimated glomerular filtration rate (eGFR) of less than 30 mL/min/1.73 m².

It is not recommended for patients with polycystic kidney disease or those requiring intravenous immunosuppressive therapy.

Medication Safety Monitoring

For patients with impaired renal function, elderly patients, or patients using loop diuretics, an assessment of intravascular volume status and renal function should be conducted before initiating medication, and relevant symptoms should be monitored during treatment.

Medication Adjustment During Special Periods

Jardiance should be discontinued for at least 3 days before undergoing major surgery or procedures involving prolonged fasting.

Regular Medical Follow-Up

Regular renal function tests should be performed under the guidance of a physician, including before treatment and when clinically necessary.

Tips for Identifying the Authenticity of Empagliflozin

Identification by Physical Characteristics

10 mg tablets: Light yellow, round, biconvex, film-coated tablets with beveled edges.

25 mg tablets: Light yellow, oval, biconvex, film-coated tablets.

Verification of Approval Number

The authenticity of the drug's approval number can be checked through the official website of the National Medical Products Administration (NMPA).